Lentigen Corporation is a privately held company, incorporated in Delaware in 2004. The company believes it offers a unique and high-potential investment opportunity because Lentiviral Vector technology will be key for the development of genetic and biopharmaceutical products. Lentigen is positioning itself as the leading manufacturer and producer of Lentiviral Vectors for research, biotechnology and medicine.